patients

It usually comes quietly into one’s life, sometimes even unnoticed, but its ripple effects can be immense. While most of the focus is rightly on how to maintain blood sugar …

Tens of millions of people with type 2 diabetes might actually be undermining their efforts to improve their health, with researchers demonstrating that the commonly prescribed metformin blocks the cardiovascular …

Clinical trial design The FIT trial was a randomised, controlled, assessor-blinded intervention trial, which investigated the effectiveness and costs of twelve monthly, 5-consecutive-days FMD cycles as an adjunct to usual …

Finerenone (Kerendia) significantly reduced urine albumin-to-creatinine ratio (UACR) by 25% from baseline to 6 months compared with the placebo for patients with type 1 diabetes (T1D) and chronic kidney disease …

The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the amount of proteins excreted in the urine of these …

Low-dose aspirin is no longer universally recommended to prevent heart health emergencies, but it might help people with type 2 diabetes, a new study says. People with type 2 diabetes …

New research suggests that those with type 2 diabetes and a genetic risk for dementia can significantly lower their odds for cognitive problems by adopting a heart-healthy lifestyle. The preliminary …

Specialty Please choose I’m not a medical professional. Allergy and Immunology Anatomy Anesthesiology Biostatistics Cardiac/Thoracic/Vascular Surgery Cardiology Critical Care Dentistry Dermatology Diabetes and Endocrinology Emergency Medicine Epidemiology and Public Health …

Somebody call Stephen King — it’s the email of the living dead. More than 500 people in the horror-writing legend’s home state received emails from their health-care system last month …

The largest study to date of real-time blood-sugar patterns among kidney-dialysis patients reveals a surprising disconnect between what standard medical tests show and what’s happening with patients’ glucose levels throughout …